Review of Cardiac Resynchronization Therapy
Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS. Related Content: Cardiac Resynchronization Therapy Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure
Publisher
JAMA Clinical Reviews
Link
edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.5869
Published
April 27, 2026
Duration
20 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
JAMA Network
JAMA Clinical Reviews
@jamaclinicalreviews
#cardiacresynchronizationtherapy #medicine
